Table 7.
Treatment | Target:Control Ratio | |||
24 Hour | 48 Hour | |||
MT1-MMP ± SEM | MMP-11 ± SEM | MT1-MMP ± SEM | MMP-11 ± SEM | |
Control | 1.00 ± 0.02 | 1.00 ± 0.02 | 1.00 ± 0.08 | 1.00 ± 0.04 |
Collagen I | 1.32 ± 0.08 | 1.35 ± 0.10 | 1.32 ± 0.08 | 1.27 ± 0.08 |
Collagen IV | 1.26 ± 0.06 | 0.68 ± 0.08 | 1.26 ± 0.06 | 0.71 ± 0.10 |
Collagen V | 1.60 ± 0.08 | 1.65 ± 0.08 | 3.55 ± 0.35 | 1.91 ± 0.08 |
Con-A | 1.00 ± 0.02 | 1.35 ± 0.12 | 1.00 ± 0.02 | 1.41 ± 0.14 |
TGF-β | 0.62 ± 0.04 | 0.56 ± 0.06 | 2.95 ± 0.25 | 1.67 ± 0.14 |
Fibronectin | 0.75 ± 0.08 | 0.72 ± 0.08 | 4.65 ± 0.38 | 2.16 ± 0.24 |
IL-1β | 0.72 ± 0.10 | 0.78 ± 0.04 | 4.32 ± 0.28 | 2.20 ± 0.24 |
IL-2 | 0.68 ± 0.08 | 0.70 ± 0.08 | 3.36 ± 0.30 | 1.57 ± 0.16 |
IL-6 | 0.70 ± 0.04 | 0.74 ± 0.04 | 1.90 ± 0.14 | 1.27 ± 0.08 |